| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Clinical-medical Affairs
1 company
Mifek Jeffrey Gerald serves as a Chief Clinical-medical Affairs at FEMY. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $8K at current prices.
The biggest single holding is FEMY (~$8K) as Chief Clinical-medical Affairs. Net of sales, the recent Form 4 record there shows accumulation of 3,125 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | FEMY Femasys Inc. | Chief Clinical-medical Affairs | Buy | 3,125 | $3.20 | $10,000.00 | New |